Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 14.15
-0.14 (-0.98%)
Jun 18, 2026, 11:42 AM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.21 billion as of June 17, 2026. Its market cap has increased by 28.79% in one year.
Market Cap
3.21B
Enterprise Value
2.68B
Revenue
897.99M
Ranking
n/a
PE Ratio
9.14
Stock Price
14.15
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.21B, a decrease of -36.03%. That is a compound annual growth rate of -18.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.41B | -19.42% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 4.28B |
| Guangzhou Innogen Pharmaceutical Group | 3.83B |
| Laekna | 3.74B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.64B |
| Medtide | 3.27B |
| Shandong Boan Biotechnology | 3.11B |
| Jiangsu Recbio Technology | 2.97B |